02009nam 2200373 450 991068841580332120230629185326.0(CKB)5400000000040800(NjHacI)995400000000040800(EXLCZ)99540000000004080020230629d2021 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierTranslational research in cancer /edited by Sivapatham Sundaresan, Yeun-Hwa GuLondon :IntechOpen,[2021]©20211 online resource (210 pages) illustrations1-78984-837-7 Includes bibliographical references.Translational research in oncology benefits from an abundance of knowledge resulting from genome-scale studies concerning the molecular pathways involved in tumorigenesis. Translational oncology represents a bridge between basic research and clinical practice in cancer medicine. The vast majority of cancer cases are due to environmental risk factors. Many of these environmental factors are controllable lifestyle choices. Experimental cancer treatments are studied in clinical trials to compare the proposed treatment to the best existing treatment through translational research. The key features of the book include: 1. New screening for the development of radioprotectors: radioprotection and anti-cancer effect of β-Glucan (Enterococcus faecalis) 2. Translational perspective on hepatocellular carcinoma 3. Brachytherapy for endometrial cancer 4. Discovery of small molecule inhibitors for histone methyltransferases in cancer.CancerResearchCancerResearch.616.9940072Sundaresan SivapathamGu Yeun-HwaNjHacINjHaclBOOK9910688415803321Translational Research in Cancer2826422UNINA